Novartis: Infections trials
The registry lists 10 Infections studies with Novartis as lead sponsor. 1 are open to participants now and 2 have results posted.
Phase 1 3Phase 3 6No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Lamprene Multiple Patient ProgramAvailableNCT04334070
- Study to Compare Efficacy and Safety of Daptomycin in Elderly Patients With Complicated Skin and Soft Tissue InfectionsCompletedNCT01184872Phase 3Results posted
- Efficacy and Safety of Basiliximab, Cyclosporine/Cyclosporine Microemulsion, and Steroids in Pediatric de Novo Liver Transplant Recipients Avoiding Intraoperative SteroidsCompletedNCT00149890Phase 3Results posted
- Immunogenicity and Safety of a Booster Dose of Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 365-569 Days Old Healthy InfantsCompletedNCT01226953Phase 3
- Immunogenicity and Safety of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 13-59 Months Old Healthy ChildrenCompletedNCT01125527Phase 3
- Study in Infants (6-12 Months) Comparing Two Doses of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Vaccine Versus a Tetanus Toxoid-Conjugated Vaccine Available for the Prevention of Haemophilus Influenzae Type b Infections in ChinaCompletedNCT01044316Phase 3
- Study in Toddlers (12-18 Months) Comparing a Booster Dose of Vaxem Hib and Hiberix Vaccines for the Prevention of Haemophilus Influenzae Type b Infections in ChinaCompletedNCT01025544Phase 3
- Comparative Bioavailability Study of Azithromycin 200mg/5mL Suspension Following a 600mg Dose Under Fed ConditionsCompletedNCT00875966Phase 1
- Comparative Bioavailability Study of 600mg Azithromycin Monohydrate Tablets Under Fasting ConditionsCompletedNCT00866216Phase 1
- To Demonstrate the Relative Bioavailability of Azithromycin 600 mg Tablets Under Fed ConditionsCompletedNCT00865670Phase 1